nach oben

Abdominal Radiology

Erschienen in:

17.08.2020 | Review

What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors

verfasst von: Matthew A. Morgan, Joanie M. Garratt, David J. Vaughn

Erschienen in: Abdominal Radiology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs expressed by germ cell tumors represent a novel approach to detection of metastatic disease during staging, surveillance, and recurrence post-therapy. It has particular promise in settings of equivocal imaging, such as clinical stage I GCT, tumor marker negative stage IIA, or after chemotherapy. These miRNAs have the potential to change typical serum marker evaluation and imaging surveillance schedules.

Einhorn EH. Testicular cancer: an oncological success story. Clin Cancer Res December 1 1997 (3) (12) 2630-2632.

Sohaib SA, Koh DM, Husband JE. The Role of Imaging in the Diagnosis, Staging, and Management of Testicular Cancer. AJR Am J Roentgenol. 2008 Aug;191(2):387-95. DOI: 10.2214/AJR.07.2758CrossRefPubMed

Hilton S, Herr HW, Teitcher JB, Begg CB, Castéllino RA. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol. 1997 Aug;169(2):521-5. DOI: 10.2214/ajr.169.2.9242768CrossRefPubMed

Baniel J, Sella A. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy. Semin Surg Oncol. 1999 Dec;17(4):263-7. DOI: 10.1002/(sici)1098-2388(199912)17:4<263::aid-ssu7>3.0.co;2-6CrossRefPubMed

Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging. 2003 Mar-Apr;28(2):155-63. https://doi.org/10.1007/s00261-001-0182-9

Gilligan TD, Hayes DF, Seidenfeld J, Temin S. ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors. J Oncol Pract. 2010 Jul;6(4):199-202. DOI: 10.1200/JOP.777010CrossRefPubMedPubMedCentral

Petrelli F, Coinu A, Cabiddu M, Ghilardi M, Borgonovo K, Lonati V, et al. Surveillance or Adjuvant Treatment With Chemotherapy or Radiotherapy in Stage I Seminoma: A Systematic Review and Meta-Analysis of 13 Studies. Clin Genitourin Cancer 2015 Oct;13(5):428-34. DOI: 10.1016/j.clgc.2015.04.005CrossRefPubMed

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol. 1997 Feb;15(2):594-603. https://doi.org/10.1200/jco.1997.15.2.594

Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature. 2005 Jun 9;435(7043):834-8. DOI: 10.1038/nature03702CrossRefPubMed

10.

Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8. doi: 10.1073/pnas.0804549105CrossRefPubMedPubMedCentral

11.

Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011 May;59(5):671-81. DOI: 10.1016/j.eururo.2011.01.044CrossRefPubMed

12.

Eini R, Dorssers LC, Looijenga LH. Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer. Int J Dev Biol. 2013;57(2-4):319-32. DOI: 10.1387/ijdb.130020reCrossRefPubMed

13.

Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006 Mar 24;124(6):1169-81. DOI: 10.1016/j.cell.2006.02.037CrossRefPubMed

14.

Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. J Urol. 2015 Jan;193(1):331-7. doi: 10.1016/j.juro.2014.07.010CrossRefPubMed

15.

Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res. 2010 Apr 1;70(7):2911-23. DOI: 10.1158/0008-5472.CAN-09-3301CrossRefPubMedPubMedCentral

16.

Valadi H Ekstrom K Bossios A et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007 Jun;9(6):654-9. DOI: 10.1038/ncb1596CrossRefPubMed

17.

Nappi, L., Neil, B.O., Daneshmand, S. Circulating miR-371a-3p for the detection of low volume viable germ cell tumor: Expanded pilot data, clinical implications and future study. Journal of Clinical Oncology 36, no. 15_suppl (May 20, 2018) 4549-4549. https://doi.org/10.1200/jco.2018.36.15_suppl.4549

18.

Gillis AJ, Rijlaarsdam MA, Eini R, Dorssers LC, Biermann K, Murray MJ, Nicholson JC, Coleman N, Dieckmann KP, Belge G, Bullerdiek J, Xu T, Bernard N, Looijenga LH. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. Mol Oncol. 2013 Dec;7(6):1083-92. doi: 10.1016/j.molonc.2013.08.002CrossRefPubMedPubMedCentral

19.

Dieckmann KP, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours. Eur Urol. 2017 Feb;71(2):213-220. doi: 10.1016/j.eururo.2016.07.029CrossRefPubMed

20.

van Agthoven T, Looijenga LHJ. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). Oncotarget. 2016 Jul 27;8(35):58037-58049. doi: 10.18632/oncotarget.10867CrossRefPubMedPubMedCentral

21.

Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. J Clin Oncol. 2019 Jun 1;37(16):1412-1423. doi: 10.1200/JCO.18.01480CrossRefPubMedPubMedCentral

22.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients. Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. https://doi.org/10.3390/ijms19103130

23.

Leão R, van Agthoven T, Figueiredo A, Jewett MAS, Fadaak K, Sweet J, Ahmad AE, Anson-Cartwright L, Chung P, Hansen A, Warde P, Castelo-Branco P, O’Malley M, Bedard PL, Looijenga LHJ, Hamilton RJ. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor. J Urol. 2018 Jul;200(1):126-135. doi: 10.1016/j.juro.2018.02.068CrossRefPubMed

24.

Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer. 1998 Apr 1;82(7):1343-51. DOI: 10.1002/(sici)1097-0142(19980401)82:7<1343::aid-cncr18>3.0.co;2-6CrossRefPubMed

25.

Charytonowicz D, Aubrey H, Bell C, Ferret M, Tsui K, Atfield R, Coleman N, Murray MJ, Wilson ECF. Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors. Clin Genitourin Cancer. 2019 Aug;17(4):e733-e744. doi: 10.1016/j.clgc.2019.03.015CrossRefPubMed

Titel: What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors
verfasst von: Matthew A. Morgan
Joanie M. Garratt
David J. Vaughn
Publikationsdatum: 17.08.2020
Verlag: Springer US
Erschienen in: Abdominal Radiology / Ausgabe 2/2021
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-020-02703-3

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors

Abstract

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Visceral adipose tissue in patients with COVID-19: risk stratification for severity

Accuracy of MRI for nodal restaging in rectal cancer: a retrospective study of 166 cases

HCC Treatment Response DFP report

Diagnostic value of spleen stiffness by magnetic resonance elastography for prediction of esophageal varices in cirrhotic patients

Non-traumatic hemoperitoneum in the ED setting: causes, characteristics, prevalence and sex differences

The follicular ring sign

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie